Cowen And Company, LLC Corbus Pharmaceuticals Holdings, Inc. Transaction History

Cowen And Company, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 08, 2021	SELL	$0.94 - $1.89 $61,194 - $123,039	-65,100 Closed	0 $0
Q3 2020 Nov 03, 2020	BUY	$1.5 - $9.38 $57,376 - $358,794	38,251 Added 142.47%	65,100 $117,000
Q2 2020 Aug 13, 2020	SELL	$4.79 - $8.39 $6,179 - $10,823	-1,290 Reduced 4.58%	26,849 $225,000
Q1 2020 May 11, 2020	BUY	$3.44 - $7.21 $96,798 - $202,882	28,139 New	28,139 $147,000

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $2.08B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Cowen And Company, LLC with notifications on news.